Oncolytics Biotech Inc ONCY

Pfizer taps McKinsey veteran Malik as new dealmaking czar

[Noteable]

" Pfizer has found a new top dealmaker to manage its rapidly growing war chest.

The company hired Aamir Malik from McKinsey & Company as its chief business innovation officer. He’ll succeed John Young, who's retiring in early 2022 after a 34-year career at Pfizer, as the drugmaker unveiled in July.

As Bourla noted in a Friday statement, Malik joins with 25 years of experience “developing innovative growth strategies, guiding mergers and acquisitions, and implementing high-impact programs” for life sciences companies.

Before his current role, Malik led the consulting firm’s global pharmaceuticals and medical products practice. He has advised “several of the most significant healthcare mergers and acquisitions of the past two decades,” according to McKinsey."

[Noteable]

Jun 16, 2021 Mckinsey Virtual meeting :  New Approaches to I/O With Innovative Partnership Models"It Takes a Village: New Approaches to I/O with Innovative Partnership Models "Collaboration among industry stakeholders is essential to discovering and developing emerging I/O approaches – where many see a promise in revolutionizing treatments for all types of cancer.  In 2020